Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Breast Cancer
Interventions: DRUG: LEE011|DRUG: Buparlisib|DRUG: Letrozole
Sponsor: Novartis Pharmaceuticals